Normative 3D gait data of healthy adults walking at three different speeds on an instrumented treadmill in virtual reality.

A normative gait dataset of 246 healthy adults (122 men / 124 women, range in age 18-91 years, body weight 46.80-116.10 kg, height 1.53-1.97 m and BMI 18.25-35.63 kg/m2) is presented and publicly shared for three walking speed conditions. Raw and processed data are presented for each subject separately and for each walking speed, including data of every single step of both legs. The subject demographics and results from the physical examination are also presented which allows researchers and clinicians to create a self-selected reference group based on specific demographics. Besides the data per individual, data are also presented in age and gender groups. This provides a quick overview of healthy gait parameters which is relevant for use in clinical practice. Three dimensional gait analysis was performed at the Computer Assisted Rehabilitation Environment (CAREN) at the Maastricht University Medical Centre (MUMC+). Subjects walked on the instrumented treadmill surrounded with twelve 3D cameras, three 2D cameras and a virtual industrial environment projected on a 180° screen using the Human Body Lower Limb Model with trunk markers (HBM-II) as biomechanical model [1], [2]. Subjects walked at comfortable walking speed, 30% slower and 30% faster. These walking speed conditions were applied in a random sequence. Comfortable walking speed was determined using a RAMP protocol: subjects started to walk at 0.5m/s and every second the speed was increased with 0.01 m/s until the preferred speed was reached. The average of three repetitions was considered the comfortable speed. For each walking speed condition, 250 steps were recorded. The 3D gait data was collected using the D-flow CAREN software. For each subject, raw data of each walking speed condition is provided in .mox files, including the output from the model such as subject data (e.g. gender, body mass, knee and ankle width), center of mass (CoM), marker and force data, kinematic data (joint angles) and kinetic data (joint moments, ground reaction forces (GRFs) and joint powers) for each single step of both legs. Unfiltered and filtered data are included. C3D files with raw marker and GRF data were recorded in Nexus (Vicon software, version 2.8.1) and are available upon request. Raw data were processed in Matlab (Mathworks 2016), including quality check, step determination and the exportation of data to .xls files. For each adult and for each walking speed, an .xls file was created, containing spatiotemporal parameters, medio-lateral (ML) and back-forward (BF) margins of stability (MoS), 3D joint angles, anterior-posterior (AP) and vertical GRFs, 3D joint moments and 3D joint power of each step of both legs. Overview files per walking speed condition are created in .xls, presenting the averaged gait parameters (calculated as average over all valid steps) of every subject. The processed data is also presented and visualized per gender for different age groups (18-29 years, 30-39 years, 40-49 years, 50-59 years, 60-69 years, ≥70 years). This can serve as normative data for treadmill based 3D gait analyses in adults, applicable for clinical and research purposes. Data is available at OSF.io (https://osf.io/t72cw/).

The VertiGO! Trial protocol: A prospective, single-center, patient-blinded study to evaluate efficacy and safety of prolonged daily stimulation with a multichannel vestibulocochlear implant prototype in bilateral vestibulopathy patients.

BACKGROUND: A combined vestibular (VI) and cochlear implant (CI) device, also known as the vestibulocochlear implant (VCI), was previously developed to restore both vestibular and auditory function. A new refined prototype is currently being investigated. This prototype allows for concurrent multichannel vestibular and cochlear stimulation. Although recent studies showed that VCI stimulation enables compensatory eye, body and neck movements, the constraints in these acute study designs prevent them from creating more general statements over time. Moreover, the clinical relevance of potential VI and CI interactions is not yet studied. The VertiGO! Trial aims to investigate the safety and efficacy of prolonged daily motion modulated stimulation with a multichannel VCI prototype. METHODS: A single-center clinical trial will be carried out to evaluate prolonged VCI stimulation, assess general safety and explore interactions between the CI and VI. A single-blind randomized controlled crossover design will be implemented to evaluate the efficacy of three types of stimulation. Furthermore, this study will provide a proof-of-concept for a VI rehabilitation program. A total of minimum eight, with a maximum of 13, participants suffering from bilateral vestibulopathy and severe sensorineural hearing loss in the ear to implant will be included and followed over a five-year period. Efficacy will be evaluated by collecting functional (i.e. image stabilization) and more fundamental (i.e. vestibulo-ocular reflexes, self-motion perception) outcomes. Hearing performance with a VCI and patient-reported outcomes will be included as well. DISCUSSION: The proposed schedule of fitting, stimulation and outcome testing allows for a comprehensive evaluation of the feasibility and long-term safety of a multichannel VCI prototype. This design will give insights into vestibular and hearing performance during VCI stimulation. Results will also provide insights into the expected daily benefit of prolonged VCI stimulation, paving the way for cost-effectiveness analyses and a more comprehensive clinical implementation of vestibulocochlear stimulation in the future. TRIAL REGISTRATION: ClinicalTrials.gov: NCT04918745. Registered 28 April 2021.

Gait alterations in patients with adult spinal deformity.

Background: Adult spinal deformity patients (ASD) experience altered spinal alignment affecting spatiotemporal parameters and joint kinematics. Differences in spinal deformity between patients with symptomatic idiopathic scoliosis (ID-ASD) and patients with "de novo" scoliosis (DN-ASD) may affect gait characteristics differently. This study aims to compare gait characteristics between ID-ASD, DN-ASD, and asymptomatic healthy matched controls. Methods: In this observational case-control study, ID-ASD (n = 24) and DN-ASD (n = 26) patients visiting the out-patient spine clinic and scheduled for long-segment spinal fusion were included. Patients were matched, based on age, gender, leg length and BMI, with asymptomatic healthy controls. Gait was measured at comfortable walking speed on an instrumented treadmill with 3D motion capture system. Trunk, pelvic and lower extremities range of motion (ROM) and spatiotemporal parameters (SPT) are presented as median (first and thirds quartile). Independent t-test or Mann-Whitney U test was used to compare ID-ASD, DN-ASD and controls. Statistical Parametric Mapping (independent t-test) was used to compare 3D joint kinematics. Results: DN-ASD patients walk with increased anterior trunk tilt during the whole gait cycle compared with ID-ASD patients and controls. ID-ASD walk with decreased trunk lateroflexion compared with DN-ASD and controls. DN-ASD showed decreased pelvic obliquity and -rotation, increased knee flexion, and decreased ankle plantar flexion. ID-ASD and DN-ASD displayed decreased trunk, pelvic and lower extremity ROM compared with controls, but increased pelvic tilt ROM. ID-ASD patients walked with comparable SPT to controls, whereas DN-ASD patients walked significantly slower with corresponding changes in SPT and wider steps. Conclusions: DN-ASD patients exhibit distinct alterations in SPT and kinematic gait characteristics compared with ID-ASD and controls. These alterations seem to be predominantly influenced by sagittal spinal malalignment and kinematic findings in ASD patients should not be generalized as such, but always be interpreted with consideration for the nature of the ASD.